Hello MEBO Community,
Our names are Megan Perusse and Lucas Bonassi, we are third year undergraduate students at Florida State University, and we are the co-leads for the 2024 FSU iGEM team. We just wanted to reach out and update the community on the 2024 project.
Each year, the iGEM team consists of new members, and those new members select a new project topic to focus on. The 2024 team was moved by the struggles of the TMAU patient community and inspired by the potential impact of the 2023 team, so we chose to continue
focusing on TMAU for this year’s project. However, we are not continuing to work on the probiotic that was developed by the 2023 team. Further research on the probiotic has been taken up by the FSU Institute for Pediatric Rare Diseases, so we unfortunately
do not have up to date information regarding the progress of that project. Along with the work being done by the Institute, some current and past members of our 2024 and 2023 teams are working to create a start-up to focus on the potential commercialization
and further development of the therapeutic and later diagnostic.
Instead, the 2024 team is focusing on developing a breathalyzer device to measure TMA levels. This would theoretically be used along with the probiotic to measure how much TMA the body is producing and therefore how much of the probiotic to use. Our hope is
that this will allow those of you in the community to gain more freedom in your lives and allow you to manage your symptoms around your life, rather than your life around your symptoms.
Our engineering team has a design and are currently ordering the supplies needed to begin testing in the lab over the next few months. We will make sure to post another update regarding our progress before the end of the competition in October. At that time,
we will share with you our project website and video presentation as well.
Thank you for your continued support, and we are working hard to help the TMAU community!
0 comments: